PMID: 375839May 1, 1979Paper

Photochemotherapy for psoriasis. A clinical cooperative study of PUVA-48 and PUVA-64

Archives of Dermatology

Abstract

A clinical cooperative study involving 14 centers evaluated photochemotherapy (psoralen and high-intensity long-wave ultraviolet light [PUVA]) for psoriasis. Results from 465 patients treated with a PUVA-48 unit (equipped with 48 high-intensity UVA bulbs) and 110 patients treated with a PUVA-64 unit (equipped with 64 high-intensity UVA bulbs) confirmed the effectiveness of photochemotherapy for psoriasis. Clearing of psoriasis occurred in 85% of patients on PUVA-48 therapy. Mean number of treatments, joules per square centimeter, to clear, and total joules at clearing were similar to other reported trials. The plateau method of clearing resulted in lower joules per square centimeter at clearing, total joules per square centimeter, and number of treatments than the nonplateau method. Maintenance therapy groups were mainly M1 (once weekly) or M4 (no treatment for more than 60 days). No meaningful laboratory abnormalities were detected and ophthalmologic examinations showed a few abnormal results following PUVA. Short-term side effects were mainly erythema, nausea, and pruritus. The effectiveness and short-term safety of PUVA for psoriasis has now been confirmed by a second large cooperative study.

Citations

Jan 1, 1980·Archives of Dermatological Research·M LandthalerO Braun-Falco
Jan 1, 1985·Archives of Dermatological Research·S C Bishop, E A Abel
Jan 1, 1987·Pharmacology & Therapeutics·M T McEvoy, R S Stern
Apr 1, 1980·Journal of the American Academy of Dermatology·E M Farber
Dec 1, 1996·Burns : Journal of the International Society for Burn Injuries·H NettelbladF Sjöberg
May 1, 1980·Journal of the American Academy of Dermatology·F S BrownH M Robinson
Aug 1, 1980·Journal of the American Academy of Dermatology·R J Coskey
May 1, 1981·Journal of the American Academy of Dermatology·W P JordanR K Hale
Mar 1, 1981·Journal of the American Academy of Dermatology·H H Roenigk, W A Caro
Mar 1, 1982·Journal of the American Academy of Dermatology·D L LevinM Lyons
Mar 1, 1983·Journal of the American Academy of Dermatology·E M FarberA Charuworn
Mar 1, 1984·The British Journal of Dermatology·H ReshadH Baker
Apr 1, 1980·The British Journal of Dermatology·L H GoldbergE A Abel
Dec 1, 1981·The British Journal of Dermatology·K J KenicerW Frain-Bell
Jul 1, 1981·Oral Surgery, Oral Medicine, and Oral Pathology·D J KrutchkoffA A Neckritz
Jul 31, 2016·Dermatology and Therapy·Benjamin FarahnikWilson Liao
Jun 4, 2014·Dermatologic Clinics·Mariam B Totonchy, Melvin W Chiu

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.